Search research articles
Contact Us
Filters
Showing results (11-20 of 100) with videos related to
Page
of 10
Sort By:
Pharmacology, Biochemistry, and Behavior
|
April 1, 1993
Effects of tianeptine on 5-HTP- and dextrofenfluramine-induced hypophagia in the rat
F Chaouloff
Presse Medicale (Paris, France : 1983)
|
November 14, 1991
[Behavioural adaptation to stress. Improvement by tianeptine]
F Chaouloff
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
November 1, 1994
Failure to find behavioural differences between lean and obese Zucker rats exposed to novel environments
F Chaouloff
Physiology & Behavior
|
October 1, 1993
Psychoneuroendocrine outcomes of short-term crowding stress
F Chaouloff, O Zamfir
Neuropharmacology
|
June 1, 1991
Influence of catecholaminergic and serotonergic receptor antagonists on the hyperglycaemic response to the neuroglucopaenic agent, 2-deoxy-D-glucose
V Baudrie, F Chaouloff
European Journal of Pharmacology
|
March 17, 1992
Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOI
V Baudrie, F Chaouloff
European Journal of Pharmacology
|
February 16, 1988
Hyperinsulinemia of the genetically obese (fa/fa) rat is decreased by a low dose of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)
F Chaouloff, B Jeanrenaud
European Journal of Pharmacology
|
June 6, 1991
Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat
V Baudrie, F Chaouloff
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1987
5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat
F Chaouloff, B Jeanrenaud
Psychoneuroendocrinology
|
January 1, 1993
Chronic treatment with an anxiolytic dose of the 5-HT1A agonist ipsapirone does not alter ipsapirone acute neuroendocrine effects
B H Schmidt, F Chaouloff
Page
of 10
Search research articles
Search
Showing results (11-20 of 100) with videos related to
Sort By:
Page
of 10
Pharmacology, Biochemistry, and Behavior
|
April 1, 1993
Effects of tianeptine on 5-HTP- and dextrofenfluramine-induced hypophagia in the rat
F Chaouloff
Presse Medicale (Paris, France : 1983)
|
November 14, 1991
[Behavioural adaptation to stress. Improvement by tianeptine]
F Chaouloff
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
November 1, 1994
Failure to find behavioural differences between lean and obese Zucker rats exposed to novel environments
F Chaouloff
Physiology & Behavior
|
October 1, 1993
Psychoneuroendocrine outcomes of short-term crowding stress
F Chaouloff, O Zamfir
Neuropharmacology
|
June 1, 1991
Influence of catecholaminergic and serotonergic receptor antagonists on the hyperglycaemic response to the neuroglucopaenic agent, 2-deoxy-D-glucose
V Baudrie, F Chaouloff
European Journal of Pharmacology
|
March 17, 1992
Mechanisms involved in the hyperglycemic effect of the 5-HT1C/5-HT2 receptor agonist, DOI
V Baudrie, F Chaouloff
European Journal of Pharmacology
|
February 16, 1988
Hyperinsulinemia of the genetically obese (fa/fa) rat is decreased by a low dose of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)
F Chaouloff, B Jeanrenaud
European Journal of Pharmacology
|
June 6, 1991
Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat
V Baudrie, F Chaouloff
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1987
5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat
F Chaouloff, B Jeanrenaud
Psychoneuroendocrinology
|
January 1, 1993
Chronic treatment with an anxiolytic dose of the 5-HT1A agonist ipsapirone does not alter ipsapirone acute neuroendocrine effects
B H Schmidt, F Chaouloff
Page
of 10